Genome Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jisoo Pae
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.2yrs |
| CEO ownership | n/a |
| Management average tenure | 5.9yrs |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
Positive Sentiment Still Eludes Genome & Company (KOSDAQ:314130) Following 31% Share Price Slump
Nov 13
Positive Sentiment Still Eludes Genome & Company (KOSDAQ:314130) Following 31% Share Price Slump
Sep 06Is Genome (KOSDAQ:314130) A Risky Investment?
Jul 03Investors Still Aren't Entirely Convinced By Genome & Company's (KOSDAQ:314130) Revenues Despite 49% Price Jump
May 27Positive Sentiment Still Eludes Genome & Company (KOSDAQ:314130) Following 25% Share Price Slump
Apr 11Is Genome (KOSDAQ:314130) Using Debt In A Risky Way?
Mar 08Genome (KOSDAQ:314130) Is In A Good Position To Deliver On Growth Plans
Mar 17CEO
Jisoo Pae
9.2yrs
Tenure
Mr. Jisoo Pae, M.D. is Director for Scioto Biosciences Inc. since 2022. He is Founder and Chief Executive Officer of Genome & Company since September 2015. Mr. Pae served as Psychiatrist at Seoul National...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & CEO | 9.2yrs | no data | no data | |
| Chief Executive Officer | 2.7yrs | no data | no data | |
| Chief Executive Officer | 1.5yrs | no data | 0.032% ₩ 28.7m | |
| Founder & CTO | 9.5yrs | no data | no data | |
| Chief Financial Officer | no data | no data | no data |
5.9yrs
Average Tenure
Experienced Management: A314130's management team is seasoned and experienced (5.9 years average tenure).